Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice

Arnon Nagler, Mark Pines, Uri Abadi, Orit Pappo, Michael Zeira, Elazar Rabbani, Dean Engelhardt, Meir Ohana, Namita Roy Chowdhury, Jayanta Roy-Chowdhury, Yaron Ilan

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

In chronic graft versus host disease (cGVHD), an immune attack by transplanted donor lymphocytes results in damage of host target organs. A disbalance between proinflammatory (Th1) and anti-inflammatory cytokines (Th2) plays an important role in the pathogenesis. Immune hyporesponsiveness induced by oral antigen administration has been shown to suppress autoimmunity. We evaluated the efficacy of oral tolerization in preventing cGVHD in a mouse model. cGVHD was generated by infusing 2.5 x 10 7 splenocytes from B10.D2 donor mice, to sublethally irradiated (6 Gy) BALB/c recipient mice, which differ in minor histocompatibility antigens. The transplantation resulted in cGVHD, with characteristic hepatic and small bowel inflammation, and increased skin collagen content and fibrosis. Oral tolerance was induced by feeding donor B10.D2 mice with proteins extracted from BALB/c splenocytes at 50 μg/d per mouse for 11 days before transplantation. Tolerization was evidenced by reduction in mixed lymphocyte response of effector splenocytes from tolerized B10.D2 mice against BALB/c target splenocytes. Liver and small bowel biopsy specimens revealed much less inflammation. Oral tolerization prevented weight and subcutaneous fat loss, reduced thickening, and skin collagen deposits. Reduction of collagen α1 (I) gene expression was shown by in situ hybridization. Serum interleukin 10 (IL- 10) levels measured significantly higher in tolerized mice than in controls, whereas interferon gamma (IFN-γ), IL-2, and tumor necrosis factor α (TNF- α) were reduced significantly. Oral tolerization of splenocyte donors towards recipient-strain splenocytes ameliorated cGVHD of the liver, small intestine, and skin. A cytokine shift from a proinflammatory to an anti- inflammatory pattern may play a role in down-regulation of the immune- mediated target organ damage.

Original languageEnglish (US)
Pages (from-to)641-648
Number of pages8
JournalHepatology
Volume31
Issue number3
StatePublished - 2000

Fingerprint

Graft vs Host Disease
Liver
Collagen
Skin
Anti-Inflammatory Agents
Transplantation
Minor Histocompatibility Antigens
Lymphocytes
Cytokines
Inflammation
Subcutaneous Fat
Autoimmunity
Interleukin-10
Interferon-gamma
Small Intestine
Interleukin-2
In Situ Hybridization
Oral Administration
Fibrosis
Down-Regulation

ASJC Scopus subject areas

  • Hepatology

Cite this

Nagler, A., Pines, M., Abadi, U., Pappo, O., Zeira, M., Rabbani, E., ... Ilan, Y. (2000). Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice. Hepatology, 31(3), 641-648.

Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice. / Nagler, Arnon; Pines, Mark; Abadi, Uri; Pappo, Orit; Zeira, Michael; Rabbani, Elazar; Engelhardt, Dean; Ohana, Meir; Chowdhury, Namita Roy; Roy-Chowdhury, Jayanta; Ilan, Yaron.

In: Hepatology, Vol. 31, No. 3, 2000, p. 641-648.

Research output: Contribution to journalArticle

Nagler, A, Pines, M, Abadi, U, Pappo, O, Zeira, M, Rabbani, E, Engelhardt, D, Ohana, M, Chowdhury, NR, Roy-Chowdhury, J & Ilan, Y 2000, 'Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice', Hepatology, vol. 31, no. 3, pp. 641-648.
Nagler A, Pines M, Abadi U, Pappo O, Zeira M, Rabbani E et al. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice. Hepatology. 2000;31(3):641-648.
Nagler, Arnon ; Pines, Mark ; Abadi, Uri ; Pappo, Orit ; Zeira, Michael ; Rabbani, Elazar ; Engelhardt, Dean ; Ohana, Meir ; Chowdhury, Namita Roy ; Roy-Chowdhury, Jayanta ; Ilan, Yaron. / Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice. In: Hepatology. 2000 ; Vol. 31, No. 3. pp. 641-648.
@article{021efb72cee5412480e8fd0e47fcf176,
title = "Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice",
abstract = "In chronic graft versus host disease (cGVHD), an immune attack by transplanted donor lymphocytes results in damage of host target organs. A disbalance between proinflammatory (Th1) and anti-inflammatory cytokines (Th2) plays an important role in the pathogenesis. Immune hyporesponsiveness induced by oral antigen administration has been shown to suppress autoimmunity. We evaluated the efficacy of oral tolerization in preventing cGVHD in a mouse model. cGVHD was generated by infusing 2.5 x 10 7 splenocytes from B10.D2 donor mice, to sublethally irradiated (6 Gy) BALB/c recipient mice, which differ in minor histocompatibility antigens. The transplantation resulted in cGVHD, with characteristic hepatic and small bowel inflammation, and increased skin collagen content and fibrosis. Oral tolerance was induced by feeding donor B10.D2 mice with proteins extracted from BALB/c splenocytes at 50 μg/d per mouse for 11 days before transplantation. Tolerization was evidenced by reduction in mixed lymphocyte response of effector splenocytes from tolerized B10.D2 mice against BALB/c target splenocytes. Liver and small bowel biopsy specimens revealed much less inflammation. Oral tolerization prevented weight and subcutaneous fat loss, reduced thickening, and skin collagen deposits. Reduction of collagen α1 (I) gene expression was shown by in situ hybridization. Serum interleukin 10 (IL- 10) levels measured significantly higher in tolerized mice than in controls, whereas interferon gamma (IFN-γ), IL-2, and tumor necrosis factor α (TNF- α) were reduced significantly. Oral tolerization of splenocyte donors towards recipient-strain splenocytes ameliorated cGVHD of the liver, small intestine, and skin. A cytokine shift from a proinflammatory to an anti- inflammatory pattern may play a role in down-regulation of the immune- mediated target organ damage.",
author = "Arnon Nagler and Mark Pines and Uri Abadi and Orit Pappo and Michael Zeira and Elazar Rabbani and Dean Engelhardt and Meir Ohana and Chowdhury, {Namita Roy} and Jayanta Roy-Chowdhury and Yaron Ilan",
year = "2000",
language = "English (US)",
volume = "31",
pages = "641--648",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice

AU - Nagler, Arnon

AU - Pines, Mark

AU - Abadi, Uri

AU - Pappo, Orit

AU - Zeira, Michael

AU - Rabbani, Elazar

AU - Engelhardt, Dean

AU - Ohana, Meir

AU - Chowdhury, Namita Roy

AU - Roy-Chowdhury, Jayanta

AU - Ilan, Yaron

PY - 2000

Y1 - 2000

N2 - In chronic graft versus host disease (cGVHD), an immune attack by transplanted donor lymphocytes results in damage of host target organs. A disbalance between proinflammatory (Th1) and anti-inflammatory cytokines (Th2) plays an important role in the pathogenesis. Immune hyporesponsiveness induced by oral antigen administration has been shown to suppress autoimmunity. We evaluated the efficacy of oral tolerization in preventing cGVHD in a mouse model. cGVHD was generated by infusing 2.5 x 10 7 splenocytes from B10.D2 donor mice, to sublethally irradiated (6 Gy) BALB/c recipient mice, which differ in minor histocompatibility antigens. The transplantation resulted in cGVHD, with characteristic hepatic and small bowel inflammation, and increased skin collagen content and fibrosis. Oral tolerance was induced by feeding donor B10.D2 mice with proteins extracted from BALB/c splenocytes at 50 μg/d per mouse for 11 days before transplantation. Tolerization was evidenced by reduction in mixed lymphocyte response of effector splenocytes from tolerized B10.D2 mice against BALB/c target splenocytes. Liver and small bowel biopsy specimens revealed much less inflammation. Oral tolerization prevented weight and subcutaneous fat loss, reduced thickening, and skin collagen deposits. Reduction of collagen α1 (I) gene expression was shown by in situ hybridization. Serum interleukin 10 (IL- 10) levels measured significantly higher in tolerized mice than in controls, whereas interferon gamma (IFN-γ), IL-2, and tumor necrosis factor α (TNF- α) were reduced significantly. Oral tolerization of splenocyte donors towards recipient-strain splenocytes ameliorated cGVHD of the liver, small intestine, and skin. A cytokine shift from a proinflammatory to an anti- inflammatory pattern may play a role in down-regulation of the immune- mediated target organ damage.

AB - In chronic graft versus host disease (cGVHD), an immune attack by transplanted donor lymphocytes results in damage of host target organs. A disbalance between proinflammatory (Th1) and anti-inflammatory cytokines (Th2) plays an important role in the pathogenesis. Immune hyporesponsiveness induced by oral antigen administration has been shown to suppress autoimmunity. We evaluated the efficacy of oral tolerization in preventing cGVHD in a mouse model. cGVHD was generated by infusing 2.5 x 10 7 splenocytes from B10.D2 donor mice, to sublethally irradiated (6 Gy) BALB/c recipient mice, which differ in minor histocompatibility antigens. The transplantation resulted in cGVHD, with characteristic hepatic and small bowel inflammation, and increased skin collagen content and fibrosis. Oral tolerance was induced by feeding donor B10.D2 mice with proteins extracted from BALB/c splenocytes at 50 μg/d per mouse for 11 days before transplantation. Tolerization was evidenced by reduction in mixed lymphocyte response of effector splenocytes from tolerized B10.D2 mice against BALB/c target splenocytes. Liver and small bowel biopsy specimens revealed much less inflammation. Oral tolerization prevented weight and subcutaneous fat loss, reduced thickening, and skin collagen deposits. Reduction of collagen α1 (I) gene expression was shown by in situ hybridization. Serum interleukin 10 (IL- 10) levels measured significantly higher in tolerized mice than in controls, whereas interferon gamma (IFN-γ), IL-2, and tumor necrosis factor α (TNF- α) were reduced significantly. Oral tolerization of splenocyte donors towards recipient-strain splenocytes ameliorated cGVHD of the liver, small intestine, and skin. A cytokine shift from a proinflammatory to an anti- inflammatory pattern may play a role in down-regulation of the immune- mediated target organ damage.

UR - http://www.scopus.com/inward/record.url?scp=17544364955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17544364955&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 641

EP - 648

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -